Myeloid Stem Cells & CML

Chronic Myeloid Leukemia (CML) is a stem cell cancer that arises due to the fusion and constitutive expression of BCR-ABL1 in hematopoietic stem cells, which give rise to both myeloid and lymphoid cell lineages. CML is characterized by increased and unregulated proliferation of myeloid cells. Here is the latest research.

September 20, 2021
Open Access

Progenitor-intrinsic Metabolic Sensing Promotes Hematopoietic Homeostasis

BioRxiv : the Preprint Server for Biology
H. A. PizzatoDeepta Bhattacharya
September 20, 2021

Changes in Bone Marrow Stromal Progenitor Cells in Patients with Hematoblastosis at the Onset of the Disease.

Bulletin of Experimental Biology and Medicine
N A PetinatiV G Savchenko
September 20, 2021

Lead Optimization and Structure-Activity Relationship Studies on Myeloid Ecotropic Viral Integration Site 1 Inhibitor.

Journal of Medicinal Chemistry
Bengisu TurgutalpMine Yarim
September 20, 2021

Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid Leukemia.

The Annals of Pharmacotherapy
Andy H SzetoDaniel J Crona
September 20, 2021

A systematic literature review of disease burden and clinical efficacy for patients with relapsed or refractory acute myeloid leukemia.

American Journal of Blood Research
Esther Natalie OlivaAntonio M Almeida
September 20, 2021

miR-506 in patients with chronic myeloid leukemia and its effect on apoptosis of K562 cells.

American Journal of Translational Research
Nafei ChenLiyun Zhao
September 20, 2021

miR-497-5p induces apoptosis in K562 cells by downregulating ROCK1.

American Journal of Translational Research
Nafei ChenLiyun Zhao
September 20, 2021

Current Progress in Delineating the Roles of Pseudokinase TRIB1 in Controlling Human Diseases.

Journal of Cancer
Xuelian ZhangXiaobo Sun
September 20, 2021
Open Access

Dysregulation of Principal Circulating miRNAs in Non-human Primates Following Ischemic Stroke.

Frontiers in Neuroscience
Jian ChenXunming Ji
September 17, 2021

Myeloid Malignancies: Recognizing the Risk of Germline Predisposition and Supporting Patients and Families.

Clinical Journal of Oncology Nursing
Patricia Friend, Suzanne M Mahon
September 16, 2021

Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report.

Journal of Cancer Research and Clinical Oncology
Ruth-Miriam KoerberAnnkristin Heine
September 16, 2021
Case Report

Concurrent Diagnosis of Acute Myeloid Leukemia and Symptomatic COVID-19 Infection: a Case Report Successfully Treated with Azacitidine-Venetoclax Combination.

Mediterranean Journal of Hematology and Infectious Diseases
Daniela TaurinoFederico Lussana
September 16, 2021

Targeting Wnt signaling in acute myeloid leukemia stem cells.

Felice PepeRamiro Garzon
September 16, 2021

In-depth time-dependent analysis of the benefit of Allo-HSCT for elderly patients with CR1 AML: a FILO study.

Blood Advances
Raynier DevillierAnne Huynh
September 16, 2021

IL-1 Mediates Microbiome-Induced Inflamm-Ageing of Hematopoietic Stem Cells in Mice.

Larisa Vladimirovna KovtonyukMarkus G Manz

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Autoimmune Disease Therapy

In autoimmune diseases, the immune system responds and attacks self-antigens and damages or impairs the function of the tissues. The treatment for autoimmune diseases often involves immunosuppressive agents, but newer treatments are being investigated. Discover the latest research on autoimmune disease therapy here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Bone Marrow Neoplasms

Bone Marrow Neoplasms are cancers that occur in the bone marrow. Discover the latest research on Bone Marrow Neoplasms here.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Cardiac Regeneration

Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.

© 2021 Meta ULC. All rights reserved